Bt玉米光合作用和生长性状的变化

在华南地区种植美国先锋公司的Bt玉米34824与其非转基因近等基因系34823,比较它们的光合作用和部分重要的生理生长性状。结果表明,Bt玉米由于Bt基因的插入和表达使植株得到保护,受玉米螟危害的叶片显著减少;但Bt玉米植株的光合作用和部分生理生长性状也发生了一定的变化。与其非转基因近等基因系34823相比,虽然Bt玉米34824的胞问CO2浓度变化不大;并且在绝大多数生长时期,Bt玉米的蒸腾速率和气孔导度大于的非转基因玉米;但是从生长中期始,Bt玉米的净光合速率却一直小于非转基因玉米,在生长后期,这种差异甚至达到显著水平。在生长性状方面,各时期观察到的Bt玉米植株叶片数一直略少于非转基因玉米,表明Bt玉米的生长发育受到一定的延缓。同时,Bt玉米植株的株高变矮,单株叶面积变小,根系活力显著降低。在地下部,Bt玉米34824的植株根系总长度、根总表面积、根总体积和平均根直径均小于相对应的非转基因近等基因系34823。     

水稻覆膜旱作对根叶性状、土壤养分和土壤微生物活性的影响

研究了水稻覆膜旱作、裸地旱作、常规水作处理对根系形态、叶片水势、土壤养分、土壤微生物数量和土壤酶活性的影响。结果表明,覆膜旱作能改善水稻田间的生态环境,提高早季土壤温度1～3℃。与裸地旱作相比,覆膜旱作能增加抽穗期水稻根系的总根长、比根长,而这些指标与常规水作差别不大。在水稻抽穗期,无论是剑叶还是倒2叶的水势,均有如下趋势：水作〉覆膜旱作〉裸地旱作,但均未达到显著水平。不同处理对叶片叶绿素含量的影响在分蘖期差异不大,中后期覆膜旱作明显高于裸地旱作和常规水作,抽穗期分别增加29．44％和15．15％,成熟期则为74．4％、38．9％。覆膜旱作能显著增加水稻的有效穗数,早季和晚季产量比裸地旱作增产10．6％和12．5％,而与常规水作差别不大。与裸地旱作和常规水作相比,覆膜旱作土壤养分含量在分蘖期除了全磷、速效氮显著增加外,其他指标差异不大。而抽穗期则由于覆膜后作物对养分的消耗加大从而使土壤养分含量下降,特别是总磷、速效磷、速效钾与常规水作相比显著下降,分别降低25．9％,31．9％,16．2％。而成熟期则大多指标与常规水作相比有所下降,但未达到显著水平。与常规水作栽培相比,覆膜旱作能增加土壤微生物细菌、真菌、放线菌2．5倍,显著增加土壤过氧化氢酶和蔗糖酶的活性,而土壤脲酶活性则差异不大。土壤过氧化氢酶活性在分蘖期、抽穗期、成熟期分别增加13．8％,81．3％,17．4％,蔗糖酶活性则分别增加42．8％,28．8％和69．9％。     

胶质细胞源性神经营养因子(ΔN39)-R9神经营养活性和透过血脑屏障的研究

为了研究胶质细胞源性神经营养因子 (GDNF) 在中枢神经系统疾病中的治疗应用,运用基因突变、蛋白质融合表达和蛋白质纯化技术获得分子质量较小的GDNF(ΔN39)活性片段. 将HIV-1 Tat 蛋白转导区 (protein transduction domain,PTD) 的9个碱性氨基酸⁴⁹RKKRRQRRR⁵⁷模拟物9个精氨酸(R9)与GDNF(ΔN39)活性片段融合表达,获得纯度达95%以上的GDNF(ΔN39)-R9融合蛋白. 将GDNF、GDNF(ΔN39)、GDNF(ΔN39)-R9分别加入原代培养的中脑多巴胺能神经元和转染GDNF受体GFRα1和Ret的PC12细胞中,观察它们的神经营养活性和毒性. 运用脑微血管内皮细胞株B-Endo 3,观察GDNF(ΔN39)-R9蛋白穿越血管内皮细胞膜的功能;运用脑血管内皮细胞和Matrigel铺板模拟血脑屏障,Transwell法检测Tat-GDNF(ΔN39)蛋白穿越脑血管内皮细胞和外周胶质膜的能力. 结果显示：GDNF(ΔN39)-R9蛋白具有类似GDNF的神经营养活性,促进原代培养的中脑多巴胺能神经元和稳定表达GFRα1和Ret受体的PC12-GFRα1-Ret细胞株的存活,没有显示毒性,并且能很好地穿过脑微血管内皮细胞层和模拟的血脑屏障.     

胶质细胞源性神经营养因子(△N39)-R9神经营养活性和透过血脑屏障的研究

为了研究胶质细胞源性神经营养因子(GDNF)在中枢神经系统疾病中的治疗应用,运用基因突变、蛋白质融合表达和蛋白质纯化技术获得分子质量较小的GDNF(△N39)活性片段.将HIV-1 Tat蛋白转导区(protein transduction domain,PTD)的9个碱性氨基酸49RKKRRQRRR57模拟物9个精氨酸(R9)与GDNF(△N39)活性片段融合表达,获得纯度达95%以上的GDNF(△N39)-R9融合蛋白.将GDNF、GDNF(△N39)、GDNF(△N39)-R9分别加入原代培养的中脑多巴胺能神经元和转染GDNF受体GFRαl和Ret的PC12细胞中,观察它们的神经营养活性和毒性.运用脑微血管内皮细胞株B-Endo 3,观察GDNF(△N39)-R9蛋白穿越血管内皮细胞膜的功能;运用脑血管内皮细胞和Matrigel铺板模拟血脑屏障,Transwell法检测Tat-GDNF(△N39)蛋白穿越脑血管内皮细胞和外周胶质膜的能力.结果显示:GDNF(△N39)-R9蛋白具有类似GDNF的神经营养活性,促进原代培养的中脑多巴胺能神经元和稳定表达GFRα1和Ret受体的PC12-GFRα1-Ret细胞株的存活,没有显示毒性,并且能很好地穿过脑微血管内皮细胞层和模拟的血脑屏障.     

鲍肽素对血管性痴呆大鼠学习与记忆能力的干预及机制研究

目的：观察鲍肤索对血管性痴呆大鼠学习与记忆能力的干预及机制。方法：制备生物鲍肤索,分剂量喂饲血管性痴呆大鼠,测试学习与记忆能力、红细胞和血红蛋白。结果：鲍肤素提高大鼠Y型迷宫测试的分值和红细胞、血红蛋白水平。结论：鲍肤素能提高血管性痴呆大鼠的学习与记忆能力和红细胞、血红蛋白水平。     

Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft

The ratio of the levels of pro-survival and pro-apoptotic members of the Bcl-2 protein family is thought to be an important regulatory factor for determining the sensitivity of the mammalian cells to apoptotic stimuli. High levels of expression of pro-survival members such as Bcl(XL) in human cancers were frequently found to be a good prognostic indicator predicting poor response to chemotherapy. The pro-survival members of the Bcl-2 family mediate their effects through heterodimerization with the BH3 region of the pro-apoptotic members. Structural analyses of the binding complex of the BH3 peptide and Bcl(XL) showed that a hydrophobic groove termed the BH3 binding cleft is the docking site for the BH3 region. Chemical mimetics of the BH3 region such as BH3I-1 that target the BH3 binding cleft indeed exhibit pro-apoptotic activities. Chelerythrine (CHE) and sanguinarine (SAN) are natural benzophenanthridine alkaloids that are structurally homologous to each other. CHE was previously identified as an inhibitor of Bcl(XL) function from a high-throughput screen of natural products, but its mode of interaction with Bcl(XL) is not known. By determining the effect of site-directed mutagenesis on ligand binding and using saturation transfer difference (STD) NMR experiments, we have verified locations of these docked ligands. Surprisingly, CHE and SAN bind separately at the BH groove and BH1 region of Bcl(XL) respectively, different from the BH3 binding cleft where other known inhibitors of Bcl(XL) target. Interestingly, certain residues on the flexible loop between helices alpha1 and alpha2 of Bcl(XL) are also perturbed upon CHE, but not SAN or BH3I-1 binding. Although CHE and SAN are similarly effective as BH3I-1 in displacing bound BH3 peptide, they are much more effective in inducing apoptosis, raising the possibility that CHE and SAN might be able to antagonize other pro-survival mechanisms in addition to the one that involves BH3 region binding.     

Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction

Background

Lung cancer remains the leading cause of cancer-related deaths worldwide. The recurrence rate ranges from 35–50% among early stage non-small cell lung cancer patients. To date, there is no fully-validated and clinically applied prognostic gene signature for personalized treatment.

Methodology/Principal Findings

From genome-wide mRNA expression profiles generated on 256 lung adenocarcinoma patients, a 12-gene signature was identified using combinatorial gene selection methods, and a risk score algorithm was developed with Naïve Bayes. The 12-gene model generates significant patient stratification in the training cohort HLM & UM (n = 256; log-rank P = 6.96e-7) and two independent validation sets, MSK (n = 104; log-rank P = 9.88e-4) and DFCI (n = 82; log-rank P = 2.57e-4), using Kaplan-Meier analyses. This gene signature also stratifies stage I and IB lung adenocarcinoma patients into two distinct survival groups (log-rank P<0.04). The 12-gene risk score is more significant (hazard ratio = 4.19, 95% CI: [2.08, 8.46]) than other commonly used clinical factors except tumor stage (III vs. I) in multivariate Cox analyses. The 12-gene model is more accurate than previously published lung cancer gene signatures on the same datasets. Furthermore, this signature accurately predicts chemoresistance/chemosensitivity to Cisplatin, Carboplatin, Paclitaxel, Etoposide, Erlotinib, and Gefitinib in NCI-60 cancer cell lines (P<0.017). The identified 12 genes exhibit curated interactions with major lung cancer signaling hallmarks in functional pathway analysis. The expression patterns of the signature genes have been confirmed in RT-PCR analyses of independent tumor samples.

Conclusions/Significance

The results demonstrate the clinical utility of the identified gene signature in prognostic categorization. With this 12-gene risk score algorithm, early stage patients at high risk for tumor recurrence could be identified for adjuvant chemotherapy; whereas stage I and II patients at low risk could be spared the toxic side effects of chemotherapeutic drugs.     

Scaffold stiffness affects the contractile function of three-dimensional engineered cardiac constructs

We investigated the effects of the initial stiffness of a three-dimensional elastomer scaffold--highly porous poly(glycerol sebacate)--on functional assembly of cardiomyocytes cultured with perfusion for 8 days. The polymer elasticity varied with the extent of polymer cross-links, resulting in three different stiffness groups, with compressive modulus of 2.35 ± 0.03 (low), 5.28 ± 0.36 (medium), and 5.99 ± 0.40 (high) kPa. Laminin coating improved the efficiency of cell seeding (from 59 ± 15 to 90 ± 21%), resulting in markedly increased final cell density, construct contractility, and matrix deposition, likely because of enhanced cell interaction and spreading on scaffold surfaces. Compact tissue was formed in the low and medium stiffness groups, but not in the high stiffness group. In particular, the low stiffness group exhibited the greatest contraction amplitude in response to electric field pacing, and had the highest compressive modulus at the end of culture. A mathematical model was developed to establish a correlation between the contractile amplitude and the cell distribution within the scaffold. Taken together, our findings suggest that the contractile function of engineered cardiac constructs positively correlates with low compressive stiffness of the scaffold.     

Effects of leachates of the invasive plant, Ageratina adenophora (Sprengel) on soil microbial community

The invasive plant Ageratina adenophora (Sprengel) changed soil microbial communities in the invaded area to facilitate its growth and inhibit native plants. However, little is known about the driving forces underlying the alteration of soil biota. Leachates from root and aerial part (stem and leaves) of A. adenophora were mixed into soil to imitate field invasion processes for evaluation of its impact on invasion of soil microbial community. The results indicated that soil microbial community was significantly changed when the soil taken from the newly-invaded area was treated with A. adenophora root and aerial part leachates for 3 and 5 weeks, respectively. The biota of newly invaded soil treated with concentration of 100 mg/mL A.adenophora leachates was much closer to that of heavily invaded soil, but was significantly different from that of control soil (newly invaded soil without treatment). A.adenophora leachates promoted growth of the seven dominant rhizosphere bacterial species in the invaded soil. The effect of A.adenophora leachates on soil biota and dominant rhizosphere bacteria was positively correlated with the concentration of leachates, however, the effect of root leachates was stronger than the aerial part leachates. It is assumed that A.adenophora change soil microbial community via nutritional and chemical communication, which helps it in better colonization of the invaded soil.     

Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: A meta-analysis

Background: Studies investigating the association between genetic polymorphism of glutathione S-transferase T1 (GSTT1) and risk of colorectal cancer have reported conflicting results. In order to clarify the effect of GSTT1 polymorphism on the risk of developing colorectal cancer, we carried out a meta-analysis using published data to obtain more precise estimates of risk. Methods: Electronic searches of PubMed and EMBASE were conducted to select studies for this meta-analysis. Papers were included if they were observational studies investigating the association between GSTT1 polymorphism and colorectal cancer risk. The principal outcome measure was the odds ratio (OR) with 95% confidence interval (CI) for the risk of colorectal cancer associated with GSTT1 null genotype. Results: We identified 30 eligible studies, which included 7635 cases and 12,911 controls. The combined results based on all studies showed that there was a statistically significant link between GSTT1 null genotype and colorectal cancer risk (OR = 1.20, 95% CI = 1.03–1.40). In the analysis of ethnic groups, we observed distinct differences associated with GSTT1 null genotype, the pooled odds ratios for the GSTT1 polymorphism were 1.32 in Caucasians (95% CI = 1.09–1.58) and 1.03 in Asians (95% CI = 0.81–1.32). As far as concerned the interaction between GSTT1 genotype and colorectal cancer risk in relation to smoking history, there was no increase in risk for smokers or nonsmokers with the GSTT1 null genotype (smokers: OR = 1.13, 95% CI = 0.80–1.60, nonsmokers: OR = 0.99, 95% CI = 0.71–1.38). When stratifying by the location of colorectal cancer, we found that there was a statistically significant link in rectal cancer (OR = 1.50, 95% CI = 1.09–2.07), but not in colon cancer (OR = 1.33, 95% CI = 0.94–1.88). No associations could be detected between null GSTT1 polymorphism and age, sex, tumor stage and differentiation. Conclusion: Our current study demonstrates that GSTT1 null genotype is associated with an increased risk of colorectal cancer, specifically, among Caucasians.